VTYX insider transaction filings
Ventyx Biosciences, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-04. Screen VTYX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for VTYX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Ventyx Biosciences, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Gonzales Roy — Senior VP, Finance | Disposition to issuer (D): 5,313 · Disposition to issuer (D): 109,200 (derivative) · Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 12,500 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 37,500 (derivative) · +1 more | EDGAR |
| 2026-03-04 | 4 | Forman Mark S — Chief Medical Officer | Disposition to issuer (D): 6,000 · Disposition to issuer (D): 85,000 (derivative) · Disposition to issuer (D): 350,000 (derivative) | EDGAR |
| 2026-03-04 | 4 | Mohan Raju — CEO AND PRESIDENT, Director | Disposition to issuer (D): 2,372,863 · Disposition to issuer (D): 23,688 (derivative) · Disposition to issuer (D): 700,000 (derivative) · Disposition to issuer (D): 155,000 (derivative) · Disposition to issuer (D): 473,750 (derivative) · Disposition to issuer (D): 370,000 (derivative) · +4 more | EDGAR |
| 2026-03-04 | 4 | Nuss John — CHIEF SCIENTIFIC OFFICER | Disposition to issuer (D): 489,481 · Disposition to issuer (D): 9,063 (derivative) · Disposition to issuer (D): 415,104 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 181,250 (derivative) · Disposition to issuer (D): 192,778 (derivative) · +3 more | EDGAR |
| 2026-03-04 | 4 | Moore Matthew Richard — Chief Operating Officer | Disposition to issuer (D): 145,000 (derivative) · Disposition to issuer (D): 320,000 (derivative) | EDGAR |
| 2026-03-04 | 4 | Cadoret-Manier Onaiza — Director | Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 15,937 (derivative) · Disposition to issuer (D): 20,427 (derivative) | EDGAR |
| 2026-03-04 | 4 | White William Richard — Director | Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 119,120 (derivative) · Disposition to issuer (D): 21,825 (derivative) · Disposition to issuer (D): 15,937 (derivative) | EDGAR |
| 2026-03-04 | 4 | GUJRATHI SHEILA — Director | Disposition to issuer (D): 130,000 · Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 662,369 (derivative) · Disposition to issuer (D): 277,941 (derivative) · +2 more | EDGAR |
| 2026-03-04 | 4 | HULME ALLISON — Director | Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 15,937 (derivative) · Disposition to issuer (D): 20,427 (derivative) | EDGAR |
| 2026-03-04 | 4 | Subramaniam Somu — Director | Disposition to issuer (D): 3,337,495 · Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 15,937 (derivative) · Disposition to issuer (D): 21,825 (derivative) | EDGAR |
| 2026-03-03 | 4 | Subramaniam Somu — Director | Other (J): 694,718 @ $0 | EDGAR |
| 2025-12-19 | 4 | Mohan Raju — CEO AND PRESIDENT, Director | Option exercise (M): 116,668 @ $0 · Sale (S): 47,345 @ $7.72 · Option exercise (M): 116,668 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Nuss John — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 34,930 @ $0 · Sale (S): 12,675 @ $7.72 · Option exercise (M): 34,930 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Forman Mark S — Chief Medical Officer | Grant/award (A): 3,000 @ $1.03 | EDGAR |
| 2025-11-19 | 4 | Gonzales Roy — Senior VP, Finance | Grant/award (A): 1,767 @ $1.03 | EDGAR |
| 2025-06-06 | 4 | Cadoret-Manier Onaiza — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | White William Richard — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Gujrathi Sheila — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | HULME ALLISON — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Subramaniam Somu — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Gonzales Roy — Senior VP, Finance | Grant/award (A): 1,750 @ $1.03 | EDGAR |
| 2025-05-16 | 4 | Forman Mark S — Chief Medical Officer | Grant/award (A): 3,000 @ $1.03 | EDGAR |
| 2025-04-03 | 4 | Nuss John — CHIEF SCIENTIFIC OFFICER | Sale (S): 1,887 @ $1.07 | EDGAR |
| 2025-04-01 | 4 | Mohan Raju — CEO AND PRESIDENT, Director | Option exercise (M): 11,844 @ $0 · Option exercise (M): 11,844 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Nuss John — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 4,531 @ $0 · Option exercise (M): 4,531 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Subramaniam Somu — Director | Other (J): 1,335,450 @ $0 | EDGAR |
| 2025-03-12 | 4 | Subramaniam Somu — Director | Other (J): 1,735,306 @ $0 | EDGAR |
| 2025-01-03 | 4 | Mohan Raju — CEO AND PRESIDENT, Director | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Nuss John — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 245,000 (derivative) @ $0 · Grant/award (A): 170,104 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Gonzales Roy — Senior VP, Finance | Grant/award (A): 109,200 (derivative) @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Forman Mark S — Chief Medical Officer | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Moore Matthew Richard — Chief Operating Officer | Grant/award (A): 145,000 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | Nuss John — CHIEF SCIENTIFIC OFFICER | Sale (S): 21,119 @ $2.36 | EDGAR |
| 2024-12-26 | 4 | Gujrathi Sheila — Director | Purchase (P): 130,000 @ $2.31 | EDGAR |
| 2024-12-19 | 4 | Nuss John — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 34,930 @ $0 · Sale (S): 13,161 @ $2.26 · Option exercise (M): 34,930 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | Mohan Raju — CEO AND PRESIDENT, Director | Option exercise (M): 116,668 @ $0 · Option exercise (M): 116,668 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Nuss John — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 5,377 @ $0.20 · Option exercise (M): 193,557 @ $0.20 · Option exercise (M): 5,377 (derivative) @ $0 · Option exercise (M): 193,557 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Mohan Raju — CEO AND PRESIDENT, Director | Purchase (P): 238,248 @ $1.83 · Purchase (P): 261,752 @ $2.01 | EDGAR |
| 2024-08-13 | 4 | Forman Mark S — Chief Medical Officer | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | NSV Partners III LP — 10% owner NSV Partners III GP LLC — 10% owner | Other (J): 641,327 @ $0 | EDGAR |
| 2024-06-26 | 4 | Subramaniam Somu — Director, 10% owner | Other (J): 641,327 @ $0 | EDGAR |
| 2024-06-11 | 4 | Mohan Raju — CEO AND PRESIDENT, Director | Option exercise (M): 96,778 @ $0.20 · Option exercise (M): 96,778 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Cadoret-Manier Onaiza — Director | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | White William Richard — Director | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Gujrathi Sheila — Director | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | HULME ALLISON — Director | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Subramaniam Somu — Director, 10% owner | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Moore Matthew Richard — Chief Operating Officer | Grant/award (A): 320,000 (derivative) @ $0 | EDGAR |
| 2024-04-16 | 4 | NSV Partners III LP — 10% owner NSV Partners III GP LLC — 10% owner | Other (J): 695,339 @ $0 | EDGAR |
| 2024-04-16 | 4 | Subramaniam Somu — Director, 10% owner | Other (J): 695,339 @ $0 | EDGAR |
Recent 8-K events — Ventyx Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-03-04 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-01-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-22 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-17 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VTYX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →